Isthmus Partners LLC lifted its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 4.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,347 shares of the biotechnology company’s stock after purchasing an additional 1,530 shares during the period. Isthmus Partners […]
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) CFO Octavio Espinoza sold 5,156 shares of the business’s stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average price of $86.66, for a total transaction of $446,818.96. Following the sale, the chief financial officer now owns 23,379 shares of […]
Ligand Pharmaceuticals (NASDAQ:LGND) Trading Up 7.3% on Strong Earnings tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Ligand Pharmaceuticals (NASDAQ:LGND) Shares Up 7.3% Following Strong Earnings wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Ligand Pharmaceuticals (NASDAQ:LGND) Issues Quarterly Earnings Results, Beats Expectations By $3.01 EPS wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.